130 related articles for article (PubMed ID: 8842049)
1. Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies.
Morrison RA; Chong S; Marino AM; Wasserman MA; Timmins P; Moore VA; Irwin WJ
Pharm Res; 1996 Jul; 13(7):1078-82. PubMed ID: 8842049
[TBL] [Abstract][Full Text] [Related]
2. Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852.
Marino AM; Chong S; Dando SA; Kripalani KJ; Bathala MS; Morrison RA
J Pharm Sci; 1996 Mar; 85(3):282-6. PubMed ID: 8699329
[TBL] [Abstract][Full Text] [Related]
3. Passive and carrier-mediated intestinal absorption components of two angiotensin converting enzyme (ACE) inhibitor prodrugs in rats: enalapril and fosinopril.
Friedman DI; Amidon GL
Pharm Res; 1989 Dec; 6(12):1043-7. PubMed ID: 2560181
[TBL] [Abstract][Full Text] [Related]
4. Intestinal absorption mechanism of dipeptide angiotensin converting enzyme inhibitors of the lysyl-proline type: lisinopril and SQ 29,852.
Friedman DI; Amidon GL
J Pharm Sci; 1989 Dec; 78(12):995-8. PubMed ID: 2559191
[TBL] [Abstract][Full Text] [Related]
5. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterisation.
Moore VA; Irwin WJ; Timmins P; Chong S; Dando SA; Morrison RA
Int J Pharm; 2000 Dec; 210(1-2):15-27. PubMed ID: 11163984
[TBL] [Abstract][Full Text] [Related]
6. A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.
Moore VA; Irwin WJ; Timmins P; Lambert PA; Chong S; Dando SA; Morrison RA
Int J Pharm; 2000 Dec; 210(1-2):29-44. PubMed ID: 11163985
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
Thwaites DT; Cavet M; Hirst BH; Simmons NL
Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
[TBL] [Abstract][Full Text] [Related]
8. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.
Dantzig AH; Tabas LB; Bergin L
Biochim Biophys Acta; 1992 Dec; 1112(2):167-73. PubMed ID: 1457450
[TBL] [Abstract][Full Text] [Related]
9. Interaction of oligonucleotide-conjugates with the dipeptide transporter system in Caco-2 cells.
Moore VA; Dunnion DJ; Brown T; Irwin WJ; Akhtar S
Biochem Pharmacol; 1997 May; 53(9):1223-8. PubMed ID: 9214682
[TBL] [Abstract][Full Text] [Related]
10. Intestinal drug transport via the proton-coupled amino acid transporter PAT1 (SLC36A1) is inhibited by Gly-X(aa) dipeptides.
Frølund S; Langthaler L; Kall MA; Holm R; Nielsen CU
Mol Pharm; 2012 Sep; 9(9):2761-9. PubMed ID: 22853447
[TBL] [Abstract][Full Text] [Related]
11. Intestinal absorption studies on peptide mimetic alpha-methyldopa prodrugs.
Wang HP; Lu HH; Lee JS; Cheng CY; Mah JR; Ku CY; Hsu W; Yen CF; Lin CJ; Kuo HS
J Pharm Pharmacol; 1996 Mar; 48(3):270-6. PubMed ID: 8737052
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin converting enzyme inhibitory tripeptides Ile-Pro-Pro and Val-Pro-Pro show increasing permeabilities with increasing physiological relevance of absorption models.
Foltz M; Cerstiaens A; van Meensel A; Mols R; van der Pijl PC; Duchateau GS; Augustijns P
Peptides; 2008 Aug; 29(8):1312-20. PubMed ID: 18490081
[TBL] [Abstract][Full Text] [Related]
14. Uptake of enalapril by rabbit small intestinal brush-border membrane vesicles.
Kitagawa S; Takeda J; Sato S
Biol Pharm Bull; 1999 Jul; 22(7):762-4. PubMed ID: 10443481
[TBL] [Abstract][Full Text] [Related]
15. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition.
Gleeson JP; Frías JM; Ryan SM; Brayden DJ
Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535
[TBL] [Abstract][Full Text] [Related]
16. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
[TBL] [Abstract][Full Text] [Related]
17. Structure-transport relationship for the intestinal small-peptide carrier: is the carbonyl group of the peptide bond relevant for transport?
Schoenmakers RG; Stehouwer MC; Tukker JJ
Pharm Res; 1999 Jan; 16(1):62-8. PubMed ID: 9950280
[TBL] [Abstract][Full Text] [Related]
18. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
19. Ethanol inhibits functional activity of the human intestinal dipeptide transporter hPepT1 expressed in Xenopus oocytes.
Li K; Xu L; Kulkarni AA; Perkins DI; Haworth IS; Davies DL
Alcohol Clin Exp Res; 2008 May; 32(5):777-84. PubMed ID: 18336632
[TBL] [Abstract][Full Text] [Related]
20. Intestinal dipeptide absorption is preserved during thermal injury and cytokine treatment.
Foster DR; Gonzales JP; Amidon GL; Welage LS
JPEN J Parenter Enteral Nutr; 2009; 33(5):520-8. PubMed ID: 19443858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
